A. B.. Utkina

A. B.. Utkina

Auto-generated profile, based on publicly available information

A. B.. Utkina

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

23 April 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
SAS.A. Aksenov
S.A. Aksenov
VKV.M. Khomyakov
V.M. Khomyakov
ARA.B. Ryabov
A.B. Ryabov
IKI.V. Kolobaev
I.V. Kolobaev
DSD.D. Sobolev
D.D. Sobolev
AKAndrei Kaprin
Andrei Kaprin
Cytoreductive surgery in combination with preoperative chemotherapy (also known as conversion surgery) is a promising treatment option for patients with limited peritoneal carcinomatosis. Local chemotherapy combined with cytoreductive procedures is widely discussed in literature as preventive approach for intraoperative dissemination. Objective. To This study aimed to evaluate the safety and efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in combination with cytoreductive surgery for patients with gastric cancer and limited peritoneal carcinomatosis (PCI < 7). Material and methods. Between 2019 and 2023, in total 20 patients with gastric cancer and limited peritoneal carcinomatosis underwent cytoreductive surgeries combined with PIPAC session at the NMIC of Radiology, Ministry of Health, Russian Federation. Results. Of the 21 patients, 3 (31.1%) had a partial response, in 17 patients primary tumor stabilization was observed after preoperative treatment, in 10 patients (50%), a complete response of peritoneal metastasis was achieved. All patients underwent complete cytoreduction (R0/CC-0). Major pathological response of the primary tumor was achived in 2 (10%) patients — TRG1a per Becker and in 4 (20%) — TRG1b per Becker, TRG2 and TRG3 in 5 (25%) and 9 (45%) patients, respectively. The median overall survival was 27 months and the disease-free survival was 7 months. 1-year and 2-year overall survival rates were 95% and 60%, respectively. Conclusion. Cytoreductive surgery in combination with PIPAC is feasible and safe. The survival rates demonstrate the potential effectiveness of this method. However, in order to make a clear assessment of the efficacy of adjuvant intraperitoneal chemotherapy as an approach for preventing intraoperative dissemination during cytoreductions, further randomized controlled trials is needed.

5 February 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
AUA.B. Utkina
A.B. Utkina
VKV.M. Khomyakov
V.M. Khomyakov
DSD.D. Sobolev
D.D. Sobolev
LBLarisa Bolotina
Larisa Bolotina
ARA.B. Ryabov
A.B. Ryabov
This article presents a clinical case of treating a 39-year-old female patient with disseminated gastric cancer after combined treatment with peritoneal carcinomatosis and ovarian metastases. The patient underwent two lines of systemic polychemotherapy and immunotherapy combined with sessions of intraperitoneal aerosol chemotherapy. The observation period exceeded 30 months.

23 April 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
AUA.B. Utkina
A.B. Utkina
ARA.B. Ryabov
A.B. Ryabov
VKV.M. Khomyakov
V.M. Khomyakov
OPO.V. Pikin
O.V. Pikin
IKI.V. Kolobaev
I.V. Kolobaev
OPO.A. Politico
O.A. Politico
The article presents clinical observations of 2 patients after perioperative polychemotherapy, who, as part of combined treatment, underwent extended resection stages in the form of gastrectomy with the formation of a high esophago-intestinal anastomosis in the mediastinum. During observations after the diagnosis of anastomosis failure, in order to separate the lumen of the defect zone from the pleural cavity, it was necessary to conduct a single thoracoscopic sanitation and program cycles of the vacuum aspiration system, thereby eliminating the complication and eliminating the possibility of extirpation of the previously formed reconstruction.

10 August 2026 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
AUA.B. Utkina
A.B. Utkina
VKV.M. Khomyakov
V.M. Khomyakov
IKI.V. Kolobaev
I.V. Kolobaev
OKO.S. Kuznetsova
O.S. Kuznetsova
ARA.B. Ryabov
A.B. Ryabov
Our work presents an extremely rare case of primary synchronous tumors in the esophagus and stomach with a similar histological type, with a different approach to treatment in a young patient. The high sensitivity of squamous cell carcinoma to drug therapy was vividly reflected in our example and clinically proven in the form of complete tumor resorption in the esophagus. Despite the generally accepted standards of treatment, we were dictated an individual treatment plan, thanks to which we managed to limit ourselves to gastric surgery, thereby avoiding the extended resection stage on the esophagus, thereby maintaining an optimal quality of life.

23 April 2024 in P.A. Herzen Journal of Oncology
Verified
Journal Article
Closed access
SAS.A. Aksenov
S.A. Aksenov
VKV.M. Khomyakov
V.M. Khomyakov
ARA.B. Ryabov
A.B. Ryabov
IKI.V. Kolobaev
I.V. Kolobaev
DSD.D. Sobolev
D.D. Sobolev
AKAndrei Kaprin
Andrei Kaprin
Conversion surgery for disseminated gastric cancer is attracting increasing attention as a new therapeutic strategy. A number of European and Asian studies on this topic have presented data on the advantage of performing cytoreductive surgery in a limited group of patients. Objective. To evaluate the safety and efficacy of conversion surgery for gastric cancer with limited peritoneal carcinomatosis. Material and methods. In the period from 2015 to 2022, 45 cytoreductive surgical interventions in patients with limited peritoneal carcinomatosis (PCI ≤7) in gastric cancer were performed in National Medical Radiology Research Center. Results. After preoperative drug treatment, 24 cases showed complete regression of carcinomatosis foci confirmed histologically and cytologically, while the remaining cases achieved partial response or stabilization. Surgical intervention was supplemented with hyperthermic intraoperative intra-abdominal chemotherapy or sessions of intra-abdominal aerosol chemotherapy. The extent of cytoreduction was considered as R0/CC-0 in 38 (84%) of 45 patients. Median overall survival was 24.1 months, with overall one- and two-year survival rates of 84.4 and 52%, respectively. Conclusion. Analysis of the results of conversion surgery for gastric cancer with limited peritoneal carcinomatosis has demonstrated the safety and efficacy of this approach with careful selection of patients. Further recruitment and analysis of the accumulated experience will make it possible to clarify the criteria for selecting patients for conversion surgery, as well as the optimal regimens of perioperative drug treatment.